NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
16/03/2022
Voltar para busca
Dado oficial do USPTO
PROCELLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PROCELLEX
ST13
US500000077226905Classe
1, 9, 42
Pedido
77226905
Registro
4004202
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
16/03/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 9, 42
Data de depósito
11/07/2007
Data de registro
02/08/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/03/2022
Última transação
16/03/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Carmiel, IL
Examinador
STEEL, ALYSSA PALADINO
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
PROTALIX LTD.
Representantes
JODY H. DRAKE SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemicalbiological and biotechnological preparations and substances for scientific and medical research userecombinant vectors for cloning; proteins and reagents for scientific and medical research usefor use in recombinant protein expression in cells; recombinant vectors and reagents for expressing recombinant DNA for industrialscientificmedical research use; chemicalbiochemicalbiological and biotechnological preparations and substancesrecombinant vectors for industrialscientificmedical research use in laboratoriesdiagnostics and analytics; chemicalbiochemicalbiological and biotechnological preparations and substancescell growth support structures medium and substrates for use in cell cultures for industrialscientific and medical research; chemicalbiochemicalbiological and biotechnological preparations and substances for use in the manufacture of medicinespharmaceuticalsdiagnosticsvaccinesantibodies and biological molecules from recombinant proteins or peptides expressed in cell culturescell growth support structures and substrates for use in cell culturesrecombinant vectors for cloning and reagents for expression of recombinant proteins; none of the foregoing being diagnostic assays for scientificresearchclinicalmedical laboratory use
Classe 9
Bioreactor for cell culturing
Classe 42
Providing medical and scientific research equipment to others for culturing cells used to produce biopharmaceuticalsrecombinant proteins; research and development for others in the field of genetically engineered plants and plant cells for producing biopharmaceuticalsrecombinant proteins; development of new technology for others in the field of recombinant biotechnology; product research and development; scientific research and industrial research for othersdrug discoverycell discoverydiscovery of recombinant proteinsgene researchenzyme researchmolecular researchgenomics and gene expression research and development; technical consultation in the field of biotechnology and in the field of recombinant production technology
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/03/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
16/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/03/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
04/11/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/08/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/07/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/07/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/07/2017
E815
TEAS SECTION 8 & 15 RECEIVED
16/05/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/05/2011
PUBO
PUBLISHED FOR OPPOSITION
17/05/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/10/2010
GNRT
NON-FINAL ACTION E-MAILED
27/10/2010
CNRT
NON-FINAL ACTION WRITTEN
27/10/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/10/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/10/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/10/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/04/2010
GNRT
NON-FINAL ACTION E-MAILED
23/04/2010
CNRT
NON-FINAL ACTION WRITTEN
23/04/2010
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
21/04/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
20/10/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
20/04/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
17/10/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/04/2008
GNSL
LETTER OF SUSPENSION E-MAILED
17/04/2008
CNSL
SUSPENSION LETTER WRITTEN
17/04/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/04/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/04/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/04/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/10/2007
GNRT
NON-FINAL ACTION E-MAILED
16/10/2007
CNRT
NON-FINAL ACTION WRITTEN
16/10/2007
DOCK
ASSIGNED TO EXAMINER
15/10/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/10/2007
ALIE
ASSIGNED TO LIE
11/10/2007
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
30/08/2007
NWAP
NEW APPLICATION ENTERED
16/07/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PROCELLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.